SLC2A1 and neoplasm: Our study demonstrates that BAY-876, a GLUT1 inhibitor, effectively induces disulfidoptosis by limiting glucose uptake and disrupting NADPH regeneration, significantly reducing tumor growth in SLC7A11-high xenograft models.